Taken together, our datasets suggest that V1a and V1b receptor activation in diabetes induces positive effects on the transdifferentiation of both alpha- and beta-cells, leading to notable benefits on pancreatic islet architecture and beta-cell mass. This evidence concerns the gene AVPR1B and diabetes mellitus.